ACTIVE

IQVIA MedTech NV

Financial year 2023 · Closed on 31/12/2023

Net result-3,5 M €-715,4 %over 1 year
Revenue5,6 M €-64,0 %over 1 year
Equity34,2 M €+205,3 %over 1 year
Workforce31,6 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

IQVIA MedTech NV is a Public limited company incorporated in 2005. Its main activity is: Technical testing and analysis. Its registered office is in Antwerpen. It employs on average 31,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0873.863.003
Incorporation
18/05/2005
Legal form
Public limited company
Registered office
Berchemstadionstraat 78
2600 Antwerpen · FlandreSee on map
Contributed capital
0,00 €
Latest accounts
31/12/2023
Average workforce
31,6 ETP
Joint committees (3)
  • 100
  • 200
  • 218
Contacts
1 public detail availableLog in to view
Signals
Solid equityLow riskGood liquidityHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 14 financial years

20232022202120172016
Income statement
Revenue5,6 M €15,6 M €13,1 M €5,4 M €4,6 M €
EBITDA-5,4 M €1,2 M €2 M €547,7 k €499,9 k €
Operating result-5,4 M €504,6 k €943,4 k €372,9 k €281,1 k €
Net result-3,5 M €575,8 k €3,5 M €224,5 k €-140,3 k €
Balance sheet
Equity34,2 M €11,2 M €10,6 M €3,1 M €2,9 M €
Total assets52,2 M €24 M €21,5 M €5,5 M €4,6 M €
Cash5 M €4 M €2 M €306,6 k €774,1 k €
Debts17,6 M €12,6 M €10,3 M €2,2 M €1,6 M €
Other
Workforce31,6 ETP31,6 ETP37,8 ETP14,1 ETP12,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2023

3 active · 31 ended

Active mandates

Clément Vanthournhout

Director · since 06 juillet 2023 · until 08 juin 2029

Active
Patrick Van Dooren

Director · since 06 juillet 2023 · until 08 juin 2029

Active
Emmanuel Vanderhaegen

Managing director · since 01 février 2023 · until 08 juin 2029

Active

Ended mandates

Brad Thomas

Director · since 01 juin 2022 · until 01 juin 2028

Ended
Frank Swaelens

Director · since 07 décembre 2020 · until 07 décembre 2026

Ended
Wouter Tack

Director · since 31 mars 2020 · until 31 mars 2026

Ended
KORYS BUSINESS SERVICES I NV

Director · since 19 juillet 2017 · until 19 juillet 2023 · 0418.759.787

Represented by Thomas De Kempeneer

Ended

Other companies at this address

Berchemstadionstraat 78 2600 Antwerpen
CompanyCBE no.
0780.480.608
0765.334.552
BURO NEXUS● Active
0628.499.622
0436.226.222
0423.205.456
0403.828.420
SwS Partners● Active
1013.013.263
TENNANT EUROPE● Active
0477.652.843
0778.969.881
TVM brokerage● Active
0429.507.486
0442.772.930
TVM solutions● Active
0472.210.351

Full financial information

Source · NBB
202320222021202020192018
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202301/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202331/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date23/12/202414/03/202528/07/202205/07/202130/07/202025/07/2019
General meeting20/12/202428/02/202526/07/202211/06/202129/07/202022/07/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202320/12/202423/12/2024DutchPDF
Full modelCorrection31/12/202228/02/202514/03/2025DutchPDF
Full model31/12/202229/11/202429/11/2024DutchPDF
Full model31/12/202126/07/202228/07/2022DutchPDF
Full model31/12/202011/06/202105/07/2021DutchPDF
Full model31/12/201929/07/202030/07/2020DutchPDF
Full model31/12/201822/07/201925/07/2019DutchPDF
Consolidated accounts31/12/201801/01/999925/07/2019DutchPDF
Full model31/12/201708/06/201806/07/2018DutchPDF
Consolidated accounts31/12/201701/01/999929/06/2018DutchPDF
Full model31/12/201609/06/201719/06/2017DutchPDF
Full model31/12/201530/06/201620/07/2016DutchPDF
Full model31/12/201412/06/201517/07/2015DutchPDF
Abridged model30/06/201307/12/201316/01/2014DutchPDF
Abridged model30/06/201201/12/201203/01/2013DutchPDF
Abridged model30/06/201103/12/201114/12/2011DutchPDF
Abridged model30/06/201004/12/201022/12/2010DutchPDF
Abridged model30/06/200905/12/200914/12/2009DutchPDF
Abridged model30/06/200806/12/200815/12/2008DutchPDF
Abridged model30/06/200701/12/200719/12/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

3 active · 31 ended

Active mandates

Clément Vanthournhout

Director · since 06 juillet 2023 · until 08 juin 2029

Active
Patrick Van Dooren

Director · since 06 juillet 2023 · until 08 juin 2029

Active
Emmanuel Vanderhaegen

Managing director · since 01 février 2023 · until 08 juin 2029

Active

Ended mandates

Brad Thomas

Director · since 01 juin 2022 · until 01 juin 2028

Ended
Frank Swaelens

Director · since 07 décembre 2020 · until 07 décembre 2026

Ended
Wouter Tack

Director · since 31 mars 2020 · until 31 mars 2026

Ended
KORYS BUSINESS SERVICES I NV

Director · since 19 juillet 2017 · until 19 juillet 2023 · 0418.759.787

Represented by Thomas De Kempeneer

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates03/08/2023
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/09/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/08/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/07/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/03/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates15/01/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other14/01/2021
    BENAMING
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 2023-3,5 M €↓
  2. 06/07/2023
    nominationEmmanuel Vanderhaegen — gedelegeerd bestuurder
  3. 06/07/2023
    nominationClément Vanthournhout — bestuurder
  4. 06/07/2023
    nominationPatrick Van Dooren — bestuurder
  5. 01/02/2023
    nominationEmmanuel Vanderhaegen — bestuurder
  6. 2022
    Annual accounts 2022575,8 k €↓
  7. 26/07/2022
    nominationMazars Bedrijfsrevisoren CV — commissaris
  8. 26/07/2022
    nominationPeter Lenoir — permanent vertegenwoordiger
  9. 01/06/2022
    nominationBrad Thomas — bestuurder
  10. 2021
    Annual accounts 20213,5 M €↑
  11. 2021
    Name changeIQVIA MedTech
  12. 2017
    Annual accounts 2017224,5 k €↑
  13. 2016
    Annual accounts 2016-140,3 k €↓
  14. 2015
    Annual accounts 2015133,6 k €↓
  15. 2014
    Annual accounts 2014155,4 k €↓
  16. 2013
    Annual accounts 2013490,6 k €↑
  17. 2012
    Annual accounts 2012487,7 k €↓
  18. 2011
    Annual accounts 2011756,3 k €↑
  19. 2010
    Annual accounts 2010226,5 k €↑
  20. 2009
    Annual accounts 200938,9 k €↓
  21. 2008
    Annual accounts 200861 k €↓
  22. 2007
    Annual accounts 2007184,9 k €
  23. 2007
    Name changeGENAE ASSOCIATES
  24. 18/05/2005
    IncorporationPublic limited company